From Mutation to Medication: Characterizing Failures of Clinical LLMs to Respect Genomic Resistance
arXiv:2611.19339v1 Announce Type: cross Abstract: Language models are increasingly proposed to support molecular tumour boards, but may recommend cancer therapies despite genomic evidence of resistance.